This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

MediJean Launches Canadian National Debate On Medical Marijuana

TORONTO, Oct. 18, 2013 /CNW/ - MediJean is pleased to announce that starting today it will be hosting a month-long online debate on the subject of medical marijuana.  The Medical Marijuana Debates will invite the public, patients, doctors, law enforcement personnel, and politicians to take part by exchanging their comments, views, and experiences with this important medicine.

"As a leader in this new industry, we felt it was important to host a national debate in order to raise awareness around medical marijuana," said Anton Mattadeen, chief strategy officer at MediJean.  "Our goal with this debate is to spur conversation around medical marijuana and bring key issues and public input onto a national stage at a scale that has never been done."

The medical marijuana industry needs informed voices as it develops.  Mattadeen says this is why MediJean is going to great efforts to host programs such as the Medical Marijuana Debates that will provide the public, patients, medical professionals and other stakeholders with industry-leading resources that cannot be found anywhere else.

Health Canada announced in June new regulations that will change the way Canadians access marijuana for medical purposes. These regulations require patients who need medical marijuana to receive a prescription from a doctor or nurse practitioner and have their medicine shipped directly to them from a Health Canada approved Licensed Producer.

"As Canada is transitioning into the new regulations, it's important to move the dialogue around medical marijuana to a point where we can have an honest and fact-based discussion," said Mattadeen. "MediJean is committed to providing doctors, patients and the public with information they can use to explore the topic, become aware of the various viewpoints and ultimately make more informed decisions on medical marijuana."

The debate will take place in an online forum, where the public, doctors, nurse practitioners and other industry stakeholders will weigh-in on discussions about medical marijuana.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs